Ex-FDA commissioner talks Houston life sciences competitiveness amid global growth

In the News
Written By Insight Designs

A panel of investors, local business leaders and a former commissioner of the Food and Drug Administration outlined the state of the biotech industry in 2026 — and where Houston could play a role.

Insight Designs
Previous

This is a For-Position-Only Event
Next

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’